Neoteric Cosmetics

Warning letter

Headquarters

United States of America

Issue date

13 Apr 2022

Issuing office

Center for Drug Evaluation and Research | CDER

Posted date

19 Apr 2022

Subject

Finished Pharmaceuticals/Unapproved New Drug/Misbranded

Products & Services

Drugs